Home

Boston Scientific (BSX)

106.14
-0.07 (-0.07%)
NYSE · Last Trade: Jul 25th, 7:57 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close106.21
Open106.18
Bid105.50
Ask106.47
Day's Range105.94 - 107.25
52 Week Range71.88 - 108.94
Volume5,875,169
Market Cap151.13B
PE Ratio (TTM)77.47
EPS (TTM)1.4
Dividend & YieldN/A (N/A)
1 Month Average Volume7,858,683

Chart

About Boston Scientific (BSX)

Boston Scientific is a global medical technology company that specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. The company focuses on providing innovative therapies for various medical conditions, including those affecting the cardiovascular, urology, and gastrointestinal systems, among others. Boston Scientific is committed to advancing patient care through its pioneering technologies, which are designed to improve outcomes and enhance the quality of life for patients around the world. Their product offerings include devices for minimally invasive procedures, enabling healthcare professionals to deliver high-quality care efficiently and effectively. Read More

News & Press Releases

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performancebenzinga.com
Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue growth.
Via Benzinga · July 25, 2025
Stocks making big moves yesterday: Power Integrations, Booz Allen Hamilton, Wendy's, SentinelOne, and Boston Scientific
Check out the companies making headlines yesterday:
Via StockStory · July 24, 2025
Beyond The Numbers: 6 Analysts Discuss Boston Scientific Stockbenzinga.com
Via Benzinga · July 24, 2025
BSX Q2 Deep Dive: Cardiovascular Momentum, New Technologies, and Global Expansion Shape Outlook
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s revenue was optimistic at $4.97 billion at the midpoint, 2.2% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 4.1% above analysts’ consensus estimates.
Via StockStory · July 24, 2025
Earnings Scheduled For July 23, 2025benzinga.com
Via Benzinga · July 23, 2025
Boston Sci Q2 Revenue Up 23 Percentfool.com
Via The Motley Fool · July 23, 2025
Stocks Jump On Trump's Trade Deal Deluge Ahead Of Big Tech Earnings: What's Moving Markets Wednesday?benzinga.com
A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets.
Via Benzinga · July 23, 2025
Why Boston Scientific (BSX) Stock Is Up Today
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.2% in the afternoon session after the company reported second-quarter financial results that surpassed Wall Street expectations and raised its full-year guidance. Boston Scientific announced net sales of $5.06 billion for the quarter, a significant 22.8% increase from the same period last year. This figure comfortably beat analysts' revenue forecasts of around $4.89 billion. The company's adjusted earnings per share (EPS) came in at $0.75, which was also higher than the consensus estimate of $0.72. The strong performance was driven by robust growth in its Cardiovascular segment, which saw sales jump 26.8%. Buoyed by these results, Boston Scientific increased its financial outlook for the full year. The company now projects full-year 2025 adjusted EPS to be between $2.95 and $2.99, an increase from its previous forecast. It also raised its expected sales growth to a range of 18% to 19% for the year.
Via StockStory · July 23, 2025
Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidancebenzinga.com
Boston Scientific beats Q2 estimates, posts 22.8% revenue growth, and raises full-year outlook on strong cardiovascular and MedSurg performance.
Via Benzinga · July 23, 2025
Boston Scientific Eyes Breakout On Strong Second Quarter, Guidanceinvestors.com
The company issued a positive outlook for 2025 that includes better-than-expected sales growth and adjusted profit.
Via Investor's Business Daily · July 23, 2025
Boston Scientific (NYSE:BSX) Reports Bullish Q2, Guides for Strong Sales Next Quarter
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s revenue was optimistic at $4.97 billion at the midpoint, 2.2% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 3.4% above analysts’ consensus estimates.
Via StockStory · July 23, 2025
What To Expect From Boston Scientific’s (BSX) Q2 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here’s what you need to know.
Via StockStory · July 21, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Contender in Growth and Momentum Investingchartmill.com
Boston Scientific Corp (NYSE:BSX) shows strong technical and growth momentum, meeting Minervini Trend Template criteria with solid earnings and revenue expansion. A potential breakout candidate for growth investors.
Via Chartmill · July 21, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) - A Strong Technical Setup in the Medical Device Sectorchartmill.com
Boston Scientific Corp (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock's consolidation near resistance and institutional support suggest potential upside.
Via Chartmill · July 18, 2025
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · July 17, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical Setupchartmill.com
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid EPS growth, margin expansion, and a bullish consolidation pattern.
Via Chartmill · July 16, 2025
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · July 9, 2025
1 Large-Cap Stock for Long-Term Investors and 2 to Ignore
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Via StockStory · July 8, 2025
1 Safe-and-Steady Stock to Research Further and 2 to Turn Down
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via StockStory · June 30, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Contender in Growth and Momentumchartmill.com
Boston Scientific Corp (NYSE:BSX) shows strong technical and fundamental growth, fitting Minervini’s trend template with high earnings momentum and improving margins. A top pick for momentum investors.
Via Chartmill · June 27, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical Setupchartmill.com
Boston Scientific Corp (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid support levels and consolidation patterns ahead of a potential breakout.
Via Chartmill · June 23, 2025
1 Growth Stock with All-Star Potential and 2 to Keep Off Your Radar
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Via StockStory · June 18, 2025
Leerink Initiates Boston Scientific Coverage With ‘Outperform’ Rating: Stock Rallies But Retail’s Not Overly Excitedstocktwits.com
The new price target of $118 represents an upside of over 18% from the stock’s closing price of $99.74 on Friday.
Via Stocktwits · June 16, 2025
This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · June 16, 2025
Deep Dive Into Boston Scientific Stock: Analyst Perspectives (13 Ratings)benzinga.com
Via Benzinga · June 16, 2025